Jounce Therapeutics, Inc. [JNCE]

Source: 

Company Overview

Jounce Therapeutics, Inc is a clinical-stage immunotherapy company dedicated to transforming the treatment of cancer by developing therapies that enable the immune system to attack tumors and provide long-lasting benefits to patients. Our strategy is to use a biomarker-driven approach from discovery through clinical development.